Involved-field radiotherapy for patients with mantle cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Involved-field radiotherapy for patients with mantle cell lymphoma

Published:2015-06-26 Issue:5 Volume:59 Page:631-639
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:Journal of Medical Imaging and Radiation Oncology

Author:

Neville Katherine E¹^ORCID,Bisquera Alessandra²,Capp Anne L³⁴

Affiliation:

1. Department of Radiation Oncology; Royal North Shore Hospital; St Leonards New South Wales Australia

2. The Hunter Medical Research Institute; New Lambton Heights New South Wales Australia

3. The University of Newcastle; Callaghan New South Wales Australia

4. Department of Radiation Oncology; Calvary Mater Newcastle; Waratah New South Wales Australia

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference16 articles.

1. AIHW Australian Cancer Database 2010

2. Open questions in the management of mantle cell lymphoma;Li;Cancer Treat Rev,2013

3. Limited-stage mantle-cell lymphoma;Leitch;Ann Oncol,2003

4. Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital;Bernard;Leuk Lymphoma,2013

5. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT);Rosenbluth;Int J Radiat Oncol Biol Phys,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy;Drugs of the Future;2022

2. Radiotherapy in mantle cell lymphoma: A literature review;Hematological Oncology;2020-02-19

3. Mantle cell lymphoma in patients not eligible for autologous stem cell transplantation;Current Opinion in Oncology;2019-09

4. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma;Blood Advances;2019-07-09

5. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents;Oncotarget;2016-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3